Michal Besser

Title: Michal Besser: Innovator in Cancer Treatment

Introduction

Michal Besser is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of cancer treatment through his innovative methods. His work focuses on improving the effectiveness of autologous adoptive cell transfer therapy.

Latest Patents

Besser holds a patent for a method of predicting responsiveness to autologous adoptive cell transfer therapy. This method involves analyzing the frequency of tumor infiltrating lymphocytes (TILs) with a specific CD8CD28CD152 signature in a subject's sample. A higher frequency of these TILs indicates a positive response to cancer treatment. The patent also discloses other signatures that reflect responsiveness to cancer treatment and methods for treating cancer based on these findings.

Career Highlights

Throughout his career, Michal Besser has worked with prominent organizations, including the Technion Research & Development Foundation Limited and Tel Hashomer Medical Research Infrastructure and Services Ltd. His work has been instrumental in advancing cancer treatment methodologies.

Collaborations

Besser has collaborated with notable colleagues such as Kfir Oved and Eran Eden. Their combined expertise has contributed to the development of innovative cancer treatment strategies.

Conclusion

Michal Besser's contributions to cancer treatment through his patented methods highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in cancer therapy.